do-me/EUR-LEX huggingface dataset:
Special report 07/2024: The Commission’s systems for recovering irregular EU expenditure – Potential to recover more and faster
Date: 2024-05-15
Institutions: European Court of Auditors
Subjects: EU Member State, EU budget, EU control, EU expenditure, EU financial instrument, EU financing arrangements, financial control, financial management, financial transparency, infringement of EU law








C_202403202EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3202


15.5.2024






Special report 07/2024:

            ‘The Commission’s systems for recovering irregular EU expenditure – Potential to recover more and faster’
         
(C/2024/3202)

The European Court of Auditors has published its special report 07/2024: ‘The Commission’s systems for recovering irregular EU expenditure – Potential to recover more and faster’.
The report can be consulted directly or downloaded at the European Court of Auditors’ website: https://www.eca.europa.eu/en/publications/sr-2024-07



ELI: http://data.europa.eu/eli/C/2024/3202/oj
ISSN 1977-091X (electronic edition)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Date: 2024-05-15
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, chromium, health control, health risk, market approval, marketing standard, metal coating, oxide, vehicle parts








C_202403120EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3120


15.5.2024






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
                (1)
)


(Text with EEA relevance)
(C/2024/3120)


Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2024) 2879


8 May 2024


dichromium tris(chromate) (EC No 246-356-2; CAS No 24613-89-6)


Monroe Czechia s.r.o., Rychnovská 383, 46342, Hodkovice nad Mohelkou, Czech Republic


REACH/24/9/0


Post-treatment of the auto-deposition coating process of shock absorbers in automotive vehicles


8 May 2026


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies.






(1)  
            OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).


ELI: http://data.europa.eu/eli/C/2024/3120/oj
ISSN 1977-091X (electronic edition)
Case T-147/23: Judgment of the General Court of 15 May 2024 – VI v Commission (Civil service – Recruitment – Notice of competition – Open competition EPSO/AST/150/21-3 – Decision not to admit the applicant to the next stage of the competition – Article 27 of the Staff Regulations – Article 5 of Annex III to the Staff Regulations – Manifest error of assessment)
Date: 2024-05-15
Institutions: General Court
Subjects: assistant, competition (EU), recruitment, technical profession








C_202403913EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3913


1.7.2024






Judgment of the General Court of 15 May 2024 – VI v Commission


(Case T-147/23)
                (1)

(Civil service - Recruitment - Notice of competition - Open competition EPSO/AST/150/21-3 - Decision not to admit the applicant to the next stage of the competition - Article 27 of the Staff Regulations - Article 5 of Annex III to the Staff Regulations - Manifest error of assessment)
(C/2024/3913)
Language of the case: Italian

Parties


Applicant: VI (represented by: M. Velardo, lawyer)

Defendant: European Commission (represented by: L. Hohenecker, I. Melo Sampaio and G. Niddam, acting as Agents)

Re:

By her action under Article 270 TFEU, the applicant seeks the annulment of the decision of the selection board of 20 May 2022 not to admit her to the third stage of competition EPSO/AST/150/21.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders VI to bear her own costs and to pay those incurred by the European Commission.






(1)  
            OJ C 179, 22.5.2023.


ELI: http://data.europa.eu/eli/C/2024/3913/oj
ISSN 1977-091X (electronic edition)
Case T-316/23: Judgment of the General Court of 15 May 2024 – Pfriem v EUIPO – U-Control (UC) (EU trade mark – Opposition proceedings – International registration designating the European Union – Figurative mark UC – Earlier EU figurative mark UC – Right to be heard – Principle of impartiality – Extent of the examination to be carried out by the Board of Appeal – Article 27(2) of Delegated Regulation (EU) 2018/625 – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001)
Date: 2024-05-15
Institutions: General Court
Subjects: EU trade mark, electrical equipment, electronic equipment, motor vehicle industry, registered trade mark, trade-mark law








C_202404086EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/4086


8.7.2024






Judgment of the General Court of 15 May 2024 – Pfriem v EUIPO – U-Control (UC)


(Case T-316/23)
                (1)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Figurative mark UC - Earlier EU figurative mark UC - Right to be heard - Principle of impartiality - Extent of the examination to be carried out by the Board of Appeal - Article 27(2) of Delegated Regulation (EU) 2018/625 - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
(C/2024/4086)
Language of the case: English

Parties


Applicant: Hanns Pfriem (Schweinfurt, Germany) (represented by: M. Pütz-Poulalion, lawyer)

Defendant: European Union Intellectual Property Office (represented by: T. Frydendahl, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: U-Control Srl (Torrile, Italy) (represented by: N. Amadei, lawyer)

Re:

By his action under Article 263 TFEU, the applicant seeks the annulment and alteration of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 16 March 2023 (Case R 1404/2022-4).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Mr Hanns Pfriem, in addition to bearing his own costs, to pay those incurred by U-Control Srl;










3.


Declares that the European Union Intellectual Property Office (EUIPO) shall bear its own costs.






(1)  
            OJ C 261, 24.7.2023.


ELI: http://data.europa.eu/eli/C/2024/4086/oj
ISSN 1977-091X (electronic edition)
Case T-181/23: Judgment of the General Court of 15 May 2024 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM) (EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM – Absolute ground for invalidity – No bad faith – Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
Date: 2024-05-15
Institutions: General Court
Subjects: EU trade mark, pharmaceutical product, registered trade mark, trade-mark law








C_202403914EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3914


1.7.2024






Judgment of the General Court of 15 May 2024 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM)


(Case T-181/23)
                (1)

(EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM - Absolute ground for invalidity - No bad faith - Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
(C/2024/3914)
Language of the case: English

Parties


Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)

Defendant: European Union Intellectual Property Office (represented by: E. Markakis, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France (Courbevoie, France) (represented by: T. de Haan and S. Vandezande, lawyers, and by J. Day, Solicitor)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 1 February 2023 (Case R 904/2022-4).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Dermavita Company S.a.r.l. to pay the costs.






(1)  
            OJ C 179, 22.5.2023.


ELI: http://data.europa.eu/eli/C/2024/3914/oj
ISSN 1977-091X (electronic edition)
Case T-257/24: Action brought on 15 May 2024 – Mazepin v Council
Date: 2024-05-15
Institutions: General Court
Subjects: EU restrictive measure, Russia, Russo-Ukrainian issue, Ukraine, economic sanctions, international sanctions, natural person, right to an effective remedy








C_202403804EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3804


24.6.2024






Action brought on 15 May 2024 – Mazepin v Council


(Case T-257/24)

(C/2024/3804)
Language of the case: English

Parties


Applicant: Nikita Dmitrievich Mazepin (Moscow, Russia) (represented by: D. Rovetta, M. Campa, M. Moretto, V. Villante, T. Marembert and A. Bass, lawyers)

Defendant: Council of the European Union

Form of order sought

The applicant claims that the Court should:






—


annul Council Decision (CFSP) 2024/847 of 12 March 2024 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine (1) and Council Implementing Regulation (EU) 2024/849 of 12 March 2024 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine (2), collectively referred to as the “Contested Acts”, in so far as the Contested Acts maintain the Applicant in the list of persons and entities made subject to the restrictive measures;










—


order the Council to bear the costs of the present proceedings.





Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.






1.


First plea in law, alleging infringement of the obligation to state reasons, of Article 296 TFEU and of Article 41(2)(c) of the Charter of Fundamental Rights; breach of the right to effective judicial protection and of Article 47 of the Charter of Fundamental Rights.










2.


Second plea in law, alleging error of assessment by the Council.






(1)  OJ L, 2024/847.

(2)  OJ L, 2024/849.


ELI: http://data.europa.eu/eli/C/2024/3804/oj
ISSN 1977-091X (electronic edition)
Case T-512/23: Judgment of the General Court of 15 May 2024 – Cellphenomics v EUIPO (CellCompDx) (EU trade mark – Application for EU word mark CellCompDx – Absolute ground for refusal – Descriptive nature – Article 7(1)(c) of Regulation (EU) 2017/1001)
Date: 2024-05-15
Institutions: General Court
Subjects: EU trade mark, drug surveillance, electronic publishing, industrial chemistry, medical diagnosis, pharmaceutical product, registered trade mark, therapeutics, trade-mark law, veterinary medicinal product








C_202403916EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3916


1.7.2024






Judgment of the General Court of 15 May 2024 – Cellphenomics v EUIPO (CellCompDx)


(Case T-512/23)
                (1)

(EU trade mark - Application for EU word mark CellCompDx - Absolute ground for refusal - Descriptive nature - Article 7(1)(c) of Regulation (EU) 2017/1001)
(C/2024/3916)
Language of the case: German

Parties


Applicant: Cellphenomics GmbH (Berlin, Germany) (represented by: C. Adori, lawyer)

Defendant: European Union Intellectual Property Office (represented by: A. Ringelhann, acting as Agent)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment and alteration of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 23 May 2023 (Case R 2571/2022-2).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders each party to bear its own costs.






(1)  
            OJ C, C/2023/36, 9.10.2023.


ELI: http://data.europa.eu/eli/C/2024/3916/oj
ISSN 1977-091X (electronic edition)
Corrigendum to Commission Delegated Regulation (EU) 2024/1261 of 11 March 2024 supplementing Regulation (EU) 2020/741 of the European Parliament and of the Council with regard to technical specifications of the key elements of risk management (Official Journal of the European Union L, 2024/1261, 8 May 2024)
Date: 2024-05-15
Institutions: European Commission
Subjects: farming sector, irrigation, public health, risk management, technical specification, wastewater, water management, water resources, water supply








L_202490303EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/1261


15.5.2024






Corrigendum to Commission Delegated Regulation (EU) 2024/1261 of 11 March 2024 supplementing Regulation (EU) 2020/741 of the European Parliament and of the Council with regard to technical specifications of the key elements of risk management

(
Official Journal of the European Union L, 2024/1261, 8 May 2024
)


The publication of Delegated Regulation (EU) 2024/1261 is to be considered null and void.


ELI: http://data.europa.eu/eli/reg_del/2024/1261/corrigendum/2024-05-15/oj
ISSN 1977-0677 (electronic edition)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Date: 2024-05-15
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, chromium, health control, health risk, market approval, marketing standard, metal coating, oxide








C_202403103EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3103


15.5.2024






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
             (1)
)

(Text with EEA relevance)
(C/2024/3103)


Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2024) 2928


8 May 2024


chromium trioxide (EC No 215-607-8; CAS No 1333-82-0)


Rubinetterie 3M S.r.l., Via E. Mattei 10, 53041 Asciano (SI), Italy


REACH/24/7/0


Electroplating of different types of substrates to achieve functional surfaces with high durability and a bright or matt silvery appearance for sanitary applications


18 February 2029


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies.






(1)  
            OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).


ELI: http://data.europa.eu/eli/C/2024/3103/oj
ISSN 1977-091X (electronic edition)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Date: 2024-05-15
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, chromium, health control, health risk, market approval, marketing standard, metal coating, oxide, printing








C_202403116EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3116


15.5.2024






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
                (1)
)


(Text with EEA relevance)
(C/2024/3116)


Decision granting an authorisation














Reference of the decision
 (2)




Date of decision




Substance name




Holder of the authorisation




Authorisation number




Authorised use




Date of expiry of review period




Reasons for the decision





C(2024) 2880


8 May 2024


chromium trioxide (EC No 215-607-8; CAS No 1333-82-0)


Maschinenfabrik Kaspar Walter GmbH & Co KG, Konrad-Zuse-Bogen 18, 82152, Krailling, Germany


REACH/24/13/0


Formulation of chromium trioxide-based electrolyte for electroplating process


31 December 2032


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies.




REACH/24/13/1


Chromium trioxide-based functional chrome plating of cylinders used in the rotogravure printing and embossing industry






(1)  
            OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).


ELI: http://data.europa.eu/eli/C/2024/3116/oj
ISSN 1977-091X (electronic edition)
Case T-235/22: Judgment of the General Court of 15 May 2024 – Russian Direct Investment Fund v Council (Common foreign and security policy – Restrictive measures adopted in view of Russia’s actions destabilising the situation in Ukraine – Prohibition on investing in, participating in or otherwise contributing to projects co-financed by the applicant – Jurisdiction of the General Court – Action for annulment – Locus standi – Admissibility – Plea of illegality – Manifest error of assessment – Rights of the defence – Freedom to conduct a business – Proportionality)
Date: 2024-05-15
Institutions: General Court
Subjects: EU restrictive measure, Russia, Russo-Ukrainian issue, Ukraine, international sanctions, investment company, legal person, principle of proportionality, right of action, rights of the defence








C_202403911EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3911


1.7.2024






Judgment of the General Court of 15 May 2024 – Russian Direct Investment Fund v Council


(Case T-235/22)
                (1)

(Common foreign and security policy - Restrictive measures adopted in view of Russia’s actions destabilising the situation in Ukraine - Prohibition on investing in, participating in or otherwise contributing to projects co-financed by the applicant - Jurisdiction of the General Court - Action for annulment - Locus standi - Admissibility - Plea of illegality - Manifest error of assessment - Rights of the defence - Freedom to conduct a business - Proportionality)
(C/2024/3911)
Language of the case: English

Parties


Applicant: Russian Direct Investment Fund (Moscow, Russia) (represented by: K. Scordis and A. Gavrielides, lawyers)

Defendant: Council of the European Union (represented by: A. Antoniadis and M. Bishop, acting as Agents)

Intervener in support of the defendant: European Commission (represented by: J.-F. Brakeland, C. Giolito and M. Carpus Carcea, acting as Agents)

Re:

By its action under Article 263 TFEU, the applicant seeks, in essence, the annulment of (i) Council Decision (CFSP) 2022/346 of 1 March 2022 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine (OJ 2022 L 63, p. 5) and (ii) Council Regulation (EU) 2022/345 of 1 March 2022 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine (OJ 2022 L 63, p. 1), in so far as those acts concern the applicant.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Russian Direct Investment Fund to bear its own costs and to pay those incurred by the Council of the European Union;










3.


Orders the European Commission to bear its own costs.






(1)  
            OJ C 237, 20.6.2022.


ELI: http://data.europa.eu/eli/C/2024/3911/oj
ISSN 1977-091X (electronic edition)